Stretta: A valuable endoscopic treatment modality for gastroesophageal reflux disease

Figure 1 Possible outcomes of proton pump inhibitor therapy in the primary care management of gastroesophageal reflux disease. PPI: Proton pump inhibitor.

Figure 2 Endoscopic appearance of the gastroesophageal junction immediately after Stretta. Antegrade view of the squamo-columnar junction (A); retrograde view of the cardia (B). White coagulation marks are seen circumferentially in both images.

Figure 3 Stretta is an adjunct in the treatment of gastroesophageal reflux disease that spans the “gap” between proton pump inhibitor responders and surgical candidates. PPI: Proton pump inhibitor; ARS: Anti-reflux surgery; “gap”: % of patients refractory to PPI not pursuing ARS.

Figure 4 Proposed algorithm for the management of patients with refractory gastroesophageal reflux disease. GERD: Gastroesophageal reflux disease; PPI: Proton pump inhibitor.